Targeting the acute promyelocytic leukemia-associated fusion proteins PML/RARα and PLZF/RARα with interfering peptides.
In acute promyelocytic leukemia (APL), hematopoietic differentiation is blocked and immature blasts accumulate in the bone marrow and blood. APL is associated with chromosomal aberrations, including t(15;17) and t(11;17). For these two translocations, the retinoic acid receptor alpha (RARα) is fused...
Main Authors: | Sabine Beez, Philipp Demmer, Elena Puccetti |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23152790/?tool=EBI |
Similar Items
-
Sulindac sulfide reverses aberrant self-renewal of progenitor cells induced by the AML-associated fusion proteins PML/RARα and PLZF/RARα.
by: Gunnar Steinert, et al.
Published: (2011-01-01) -
Detection of Promyelocytic Leukemia/Retinoic Acid Receptor α (PML/RARα) Fusion Gene with Functionalized Graphene Oxide
by: Hongwei Wang, et al.
Published: (2013-06-01) -
PLZF-RAR<sub>α</sub>, NPM1-RAR<sub>α</sub>, and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review
by: Marta Sobas, et al.
Published: (2020-05-01) -
Disruption of Transcription by the Oncogene PML-RARα in Acute Promyelocytic Leukemia and Regulation of the Tumor Suppressor PML in Breast Cancer
by: Reineke, Erin Lynn
Published: (2008) -
Disruption of the PHRF1 Tumor Suppressor Network by PML-RARα Drives Acute Promyelocytic Leukemia Pathogenesis
by: Céline Prunier, et al.
Published: (2015-02-01)